The Company has developed the commercially available intelligent robotic radiosurgery system, the CyberKnife system, designed to treat solid tumors anywhere in the body as an alternative to traditional surgery.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
This longshot has an interesting product in CyberKnife and with a global distributional and mutual back scratching hook up with Siemens AG deserves a hard look while in the pennies. I will add though,in a market like this you just might get it cheaper with Management looking to the lower end of guidance. Other than that Looks good post parade,and should at least bring those long odds in the trifecta to add value,good shot to get in the exacta,ha!ha!
Accuray has the proven technology and it is being used to enable patients to have their tumor removed both safely and quickly without pain and there is no invasion of the patient's body or hospital stay needed.
Yea,it does appear to be an interesting company with several things going on. The only reason I can figure it cratered is the founder resigned from the board and went to Varian, another company,still owns a stake,maybe he wants his cake and eat it too or a double pay off,maybe he figured the new management could do a better job,nothing wrong with that and to be honest more good things have happened for the company since his departure such as Shonin approval, the hook up with Siemens AG.
Good luck investing and have a nice day.